Home > Financial Ratios > AURO LABORATORIES

AURO LABORATORIES
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for AURO LABORATORIES
Please provide your vote to see the results

AURO LABORATORIES Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 128.22-6.71-52.3565.67-8.91

What is the latest Core EBITDA Growth ratio of AURO LABORATORIES ?

The latest Core EBITDA Growth ratio of AURO LABORATORIES is 128.22 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar2024128.22
Mar2023-6.71
Mar2022-52.35
Mar202165.67
Mar2020-8.91

How is Core EBITDA Growth of AURO LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2024 128.22
Positive
Mar2023 -6.71
Negative
Mar2022 -52.35
Negative
Mar2021 65.67
Positive
Mar2020 -8.91 -

Other Financial Ratios of AURO LABORATORIES


Compare Core EBITDA Growth ratio of peers of AURO LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AURO LABORATORIES ₹138.8 Cr -4.3% -3.1% 64.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,697.0 Cr -2% -0.8% 16.6% Stock Analytics
DIVIS LABORATORIES ₹157,449.0 Cr -2.7% 3.5% 66.7% Stock Analytics
CIPLA ₹117,778.0 Cr 0.7% 1.4% 3.7% Stock Analytics
DR REDDYS LABORATORIES ₹101,871.0 Cr 0.1% -8.5% 0.7% Stock Analytics
ZYDUS LIFESCIENCES ₹97,046.2 Cr -0.9% -1% 24% Stock Analytics


AURO LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AURO LABORATORIES

-4.3%

-3.1%

64.1%

SENSEX

0.2%

-0.1%

7.2%


You may also like the below Video Courses